These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 31205812)

  • 1. Evaluation of Liposomal and Conventional Amphotericin B in Experimental Fungal Keratitis Rabbit Model.
    Ghosh AK; Rudramurthy SM; Gupta A; Choudhary H; Singh S; Thakur A; Jatana M
    Transl Vis Sci Technol; 2019 May; 8(3):35. PubMed ID: 31205812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solid Dispersion Incorporated into Dissolving Microneedles for Improved Antifungal Activity of Amphotericin B:
    Mahfud MAS; Syahirah NA; Akram M; Mahfufah U; Saputra MD; Elim D; Andi MNF; Sultan NAF; Himawan A; Domínguez-Robles J; Pamornpathomkul B; Mir M; Permana AD
    Mol Pharm; 2023 Dec; 20(12):6246-6261. PubMed ID: 37975721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized comparative trial evaluating the safety and efficacy of liposomal amphotericin B (Fungisome) versus conventional amphotericin B in the empirical treatment of febrile neutropenia in India.
    Jadhav MP; Shinde VM; Chandrakala S; Jijina F; Menon H; Arora B; Kurkure PA; Parikh PM; Kshirsagar NA
    Indian J Cancer; 2012; 49(1):107-13. PubMed ID: 22842177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amphotericin B containing microneedle ocular patch for effective treatment of fungal keratitis.
    Roy G; Galigama RD; Thorat VS; Mallela LS; Roy S; Garg P; Venuganti VVK
    Int J Pharm; 2019 Dec; 572():118808. PubMed ID: 31678387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical caspofungin for treatment of keratitis caused by Candida albicans in a rabbit model.
    Goldblum D; Frueh BE; Sarra GM; Katsoulis K; Zimmerli S
    Antimicrob Agents Chemother; 2005 Apr; 49(4):1359-63. PubMed ID: 15793112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacies of high-dose fluconazole plus amphotericin B and high-dose fluconazole plus 5-fluorocytosine versus amphotericin B, fluconazole, and 5-fluorocytosine monotherapies in treatment of experimental endocarditis, endophthalmitis, and pyelonephritis due to Candida albicans.
    Louie A; Liu W; Miller DA; Sucke AC; Liu QF; Drusano GL; Mayers M; Miller MH
    Antimicrob Agents Chemother; 1999 Dec; 43(12):2831-40. PubMed ID: 10582868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized comparison of liposomal versus conventional amphotericin B for the treatment of pyrexia of unknown origin in neutropenic patients.
    Prentice HG; Hann IM; Herbrecht R; Aoun M; Kvaloy S; Catovsky D; Pinkerton CR; Schey SA; Jacobs F; Oakhill A; Stevens RF; Darbyshire PJ; Gibson BE
    Br J Haematol; 1997 Sep; 98(3):711-8. PubMed ID: 9332329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative efficacy and distribution of lipid formulations of amphotericin B in experimental Candida albicans infection of the central nervous system.
    Groll AH; Giri N; Petraitis V; Petraitiene R; Candelario M; Bacher JS; Piscitelli SC; Walsh TJ
    J Infect Dis; 2000 Jul; 182(1):274-82. PubMed ID: 10882607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro antifungal activity of Indian liposomal amphotericin B against clinical isolates of emerging species of yeast and moulds, and its comparison with amphotericin B deoxycholate, voriconazole, itraconazole and fluconazole.
    Rudramurthy SM; Jatana M; Singh R; Chakrabarti A
    Mycoses; 2013 Jan; 56(1):39-46. PubMed ID: 22519679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rabbit model of Candida albicans biofilm infection: liposomal amphotericin B antifungal lock therapy.
    Schinabeck MK; Long LA; Hossain MA; Chandra J; Mukherjee PK; Mohamed S; Ghannoum MA
    Antimicrob Agents Chemother; 2004 May; 48(5):1727-32. PubMed ID: 15105127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-marketing study to assess the safety, tolerability and effectiveness of Fungisome: an Indian liposomal amphotericin B preparation.
    Sanath SS; Gogtay NJ; Kshirsagar NA
    J Postgrad Med; 2005; 51 Suppl 1():S58-63. PubMed ID: 16519258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formulation and optimization of nanoemulsion using antifungal lipid and surfactant for accentuated topical delivery of Amphotericin B.
    Hussain A; Singh VK; Singh OP; Shafaat K; Kumar S; Ahmad FJ
    Drug Deliv; 2016 Oct; 23(8):3101-3110. PubMed ID: 27854145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corneal concentrations following systemic administration of amphotericin B and its lipid preparations in a rabbit model.
    Goldblum D; Rohrer K; Frueh BE; Theurillat R; Thormann W; Zimmerli S
    Ophthalmic Res; 2004; 36(3):172-6. PubMed ID: 15103209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liposomal amphotericin B: a review of its use as empirical therapy in febrile neutropenia and in the treatment of invasive fungal infections.
    Moen MD; Lyseng-Williamson KA; Scott LJ
    Drugs; 2009; 69(3):361-92. PubMed ID: 19275278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toxicities and pharmacokinetics of subconjunctival injection of liposomal amphotericin B.
    Kaji Y; Yamamoto E; Hiraoka T; Oshika T
    Graefes Arch Clin Exp Ophthalmol; 2009 Apr; 247(4):549-53. PubMed ID: 19043733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of amphotericin B on Aspergillus flavus clinical isolates with variable susceptibilities to the polyene in an experimental model of systemic aspergillosis.
    Barchiesi F; Spreghini E; Sanguinetti M; Giannini D; Manso E; Castelli P; Girmenia C
    J Antimicrob Chemother; 2013 Nov; 68(11):2587-91. PubMed ID: 23794598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antifungal activity of amphotericin B-lipid admixtures in experimental systemic candidosis in naive mice.
    Shadkchan Y; Segal E
    J Antimicrob Chemother; 1999 Dec; 44(6):787-90. PubMed ID: 10590279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of visceral leishmaniasis: anomalous pricing and distribution of AmBisome and emergence of an indigenous liposomal amphotericin B, FUNGISOME.
    Bhattacharya P; Ali N
    J Parasit Dis; 2016 Sep; 40(3):1094-5. PubMed ID: 27605844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose induction liposomal amphotericin B followed by de-escalation is effective in experimental Aspergillus terreus pneumonia.
    Lewis RE; Albert NP; Liao G; Wang W; Prince RA; Kontoyiannis DP
    J Antimicrob Chemother; 2013 May; 68(5):1148-51. PubMed ID: 23349440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic and hemolytic evaluation of in-situ liposomal preparation containing amphotericin - beta complexed with different chemically modified beta - cyclodextrins.
    Chakraborty KK; Naik SR
    J Pharm Pharm Sci; 2003; 6(2):231-7. PubMed ID: 12935435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.